Company intelligence / Profile preview

Senscio Systems

Harvard, Massachusetts, United Statessensciosystems.com ↗

Ownership: Private
Development stage: Other

Overview

Senscio Systems has developed and commercialized the Ibis™ Health Program, an AI-powered home-to-clinic digital therapeutics solution that supports self-management of multiple chronic conditions. The system uses proprietary AI to contextualize patient data into actionable insights for both patients and their healthcare teams. It is covered by Medicare Part B and has demonstrated reductions in avoidable hospital admissions while improving outcomes for older adults with complex health needs[1][2][3][4].

Therapeutic areas: Other
Modalities: DeviceDigital therapeuticsRemote patient monitoring platform (software/device-enabled)
Industry: Digital Health Medical Devices

Partnerships

Medical practices, insurance companiesHealthcare partners in Maine

Beyond the preview

Go deeper on Senscio Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Senscio Systems.

Explore the full profile